Core Viewpoint - The company is transforming its international business model from traditional product export to an integrated platform approach, focusing on building a global health ecosystem through collaboration with local healthcare systems and public health institutions [2] Group 1: International Market Strategy - The company aims to upgrade its international business from "single-point cooperation" to "ecological collaboration" by leveraging a "platform integration and diagnostic integration" strategy [2] - In response to the high standards and specialization demands of the European market, the company is developing a tailored ecosystem model that includes "high-end diagnostics, customized services, and partner collaboration" [2] Group 2: Sales and Localization - The company's sales strategy primarily relies on distribution, supplemented by direct sales, utilizing local subsidiaries in countries like France and the UK to enhance market penetration [2] - The company is focused on building localized teams, regional service networks, and implementing benchmark projects to strengthen its international ecological construction [2]

证券日报网讯 2月6日，圣湘生物在互动平台回答投资者提问时表示，公司以"平台一体化、诊疗一体 化"为核心引擎，深度链接全球产业链伙伴、当地医疗体系与公共卫生机构，构建起"技术共享-能力共 建-价值共生"的全球健康生态，推动国际业务从"单点合作"向"生态协同"升级。2025年，公司海外深耕 取得长足发展，业务版图稳步拓展，全球资源配置效率有效提升。公司于今年1月对德国inno- trainDiagnostikGmbH的收购，是公司国际化战略的又一项重要战略布局，进一步强化了公司在高端血液 分子诊断领域的全球布局，为构建全链条诊疗一体化生态注入关键动能。公司高度重视资产减值与商誉 评估，年度报告财务数据均严格遵循会计准则并经过审计，具体内容可详见公司披露的财务报表及其附 注。 （文章来源：证券日报） ...